Varnimcabtagene autoleucel
Sponsors
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer, Fundacio Sant Joan De Deu
Conditions
Acute lymphoblastic leukemiaAcute lymphoid leukemia
Phase 2
Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B1) conjugated with the co-stimulatory regions 4-1BB and CD3z (ARI-0001 cells) in patients with CD19+ acute lymphoid leukemia resistant or refractory to therapy
Not yet recruitingCTIS2024-513601-31-00
Target: 32Updated: 2024-10-24
Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B1) conjugated with the co-stimulatory regions 4-1BB and CD3z (ARI-0001 cells) in children and adolescents aged 0-18 years with CD19+ acute lymphoblastic leukaemia resistant or refractory to treatment.
Active, not recruitingCTIS2024-515467-66-00
Start: 2024-07-22Target: 33Updated: 2026-01-16